PaxMedica, Inc. Common Stock – NASDAQ:PXMD

PaxMedica, Inc. Common Stock stock price today

$0
-0.06
-99.84%
Financial Health
0
1
2
3
4
5
6
7
8
9

PaxMedica, Inc. Common Stock stock price monthly change

-70.67%
month

PaxMedica, Inc. Common Stock stock price quarterly change

-70.67%
quarter

PaxMedica, Inc. Common Stock stock price yearly change

-92.34%
year

PaxMedica, Inc. Common Stock key metrics

Market Cap
772.42K
Enterprise value
14.00M
P/E
-1.1
EV/Sales
N/A
EV/EBITDA
-1.05
Price/Sales
N/A
Price/Book
144.62
PEG ratio
0.01
EPS
-18.5
Revenue
N/A
EBITDA
-16.25M
Income
-18.14M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

PaxMedica, Inc. Common Stock stock price history

PaxMedica, Inc. Common Stock stock forecast

PaxMedica, Inc. Common Stock financial statements

PaxMedica, Inc. Common Stock (NASDAQ:PXMD): Profit margin
Jun 2023 0 -3.48M
Sep 2023 0 -5.04M
Dec 2023 0 -5.92M
Mar 2024 0 -3.69M
PaxMedica, Inc. Common Stock (NASDAQ:PXMD): Earnings per share (EPS)
2024-04-03 -0.88 -10.03
2024-05-13 -0.43 -0.5
PaxMedica, Inc. Common Stock (NASDAQ:PXMD): Debt to assets
Jun 2023 5144242 2.87M 55.96%
Sep 2023 3233577 3.77M 116.6%
Dec 2023 5680405 2.29M 40.41%
Mar 2024 2893103 1.70M 58.87%
PaxMedica, Inc. Common Stock (NASDAQ:PXMD): Cash Flow
Jun 2023 -2.83M 0 1.91M
Sep 2023 -2.33M 0 414.86K
Dec 2023 -2.61M 0 6.17M
Mar 2024 -3.06M 0 -15.27K

PaxMedica, Inc. Common Stock alternative data

PaxMedica, Inc. Common Stock (NASDAQ:PXMD): Employee count
Aug 2023 3
Sep 2023 3
Oct 2023 3
Nov 2023 3
Dec 2023 3
Jan 2024 3
Feb 2024 3
Mar 2024 6
Apr 2024 6
May 2024 6
Jun 2024 6
Jul 2024 6

PaxMedica, Inc. Common Stock other data

0.46% -0.49%
of PXMD is owned by hedge funds
39.81K -46.64K
shares is hold by hedge funds

PaxMedica, Inc. Common Stock (NASDAQ:PXMD): Insider trades (number of shares)
Period Buy Sel
Mar 2023 0 269463
Aug 2023 0 136517
Transaction Date Insider Security Shares Price per share Total value Source
Sale
ROME ZACHARY director Common Stock 4,801 $0.47 $2,237
Sale
WEISMAN HOWARD J. director, officer: Chairman and..
Common Stock 22,535 $0.45 $10,051
Sale
ROME ZACHARY director Common Stock 8,792 $0.48 $4,255
Sale
DERBY MICHAEL 10 percent owner
Common Stock 6,540 $0.49 $3,172
Sale
LAROCHELLE KAREN director
Common Stock 456 $0.49 $221
Sale
COELHO JOHN F director
Common Stock 23 $0.49 $11
Sale
WEISMAN HOWARD J. director, officer: Chairman and..
Common Stock 9,596 $0.49 $4,654
Sale
ROME ZACHARY director Common Stock 12,000 $0.49 $5,868
Sale
DERBY MICHAEL 10 percent owner
Common Stock 7,000 $0.49 $3,451
Sale
COELHO JOHN F director
Common Stock 774 $0.52 $403
Tuesday, 3 September 2024
accesswire.com
Tuesday, 27 August 2024
accesswire.com
Wednesday, 15 May 2024
globenewswire.com
Tuesday, 23 April 2024
globenewswire.com
Tuesday, 16 April 2024
globenewswire.com
Monday, 15 April 2024
PennyStocks
Friday, 12 April 2024
Invezz
InvestorPlace
Wednesday, 22 November 2023
InvestorPlace
Monday, 20 November 2023
InvestorPlace
Tuesday, 7 November 2023
PennyStocks
Thursday, 26 October 2023
InvestorPlace
PennyStocks
Wednesday, 30 August 2023
GlobeNewsWire
Monday, 24 July 2023
InvestorPlace
Thursday, 22 June 2023
Market Watch
Friday, 10 March 2023
PennyStocks
Monday, 6 February 2023
PennyStocks
Sunday, 5 February 2023
PennyStocks
Friday, 3 February 2023
InvestorPlace
PennyStocks
Wednesday, 25 January 2023
InvestorPlace
Tuesday, 24 January 2023
Finbold
Wednesday, 28 December 2022
PennyStocks
Friday, 2 December 2022
PennyStocks
Tuesday, 22 November 2022
GlobeNewsWire
Monday, 21 November 2022
InvestorPlace
PennyStocks
Saturday, 19 November 2022
PennyStocks
Friday, 18 November 2022
InvestorPlace
  • What's the price of PaxMedica, Inc. Common Stock stock today?

    One share of PaxMedica, Inc. Common Stock stock can currently be purchased for approximately $0.

  • When is PaxMedica, Inc. Common Stock's next earnings date?

    Unfortunately, PaxMedica, Inc. Common Stock's (PXMD) next earnings date is currently unknown.

  • Does PaxMedica, Inc. Common Stock pay dividends?

    No, PaxMedica, Inc. Common Stock does not pay dividends.

  • How much money does PaxMedica, Inc. Common Stock make?

    PaxMedica, Inc. Common Stock has a market capitalization of 772.42K. PaxMedica, Inc. Common Stock made a loss 18.29M US dollars in net income (profit) last year or -$0.5 on an earnings per share basis.

  • What is PaxMedica, Inc. Common Stock's stock symbol?

    PaxMedica, Inc. Common Stock is traded on the NASDAQ under the ticker symbol "PXMD".

  • What is PaxMedica, Inc. Common Stock's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of PaxMedica, Inc. Common Stock?

    Shares of PaxMedica, Inc. Common Stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does PaxMedica, Inc. Common Stock have?

    As Jul 2024, PaxMedica, Inc. Common Stock employs 6 workers.

  • When PaxMedica, Inc. Common Stock went public?

    PaxMedica, Inc. Common Stock is publicly traded company for more then 3 years since IPO on 26 Aug 2022.

  • What is PaxMedica, Inc. Common Stock's official website?

    The official website for PaxMedica, Inc. Common Stock is paxmedica.com.

  • Where are PaxMedica, Inc. Common Stock's headquarters?

    PaxMedica, Inc. Common Stock is headquartered at 303 South Broadway, Tarrytown, NY.

  • How can i contact PaxMedica, Inc. Common Stock?

    PaxMedica, Inc. Common Stock's mailing address is 303 South Broadway, Tarrytown, NY and company can be reached via phone at +91 49872876.

PaxMedica, Inc. Common Stock company profile:

PaxMedica, Inc. Common Stock

paxmedica.com
Exchange:

NASDAQ

Full time employees:

6

Industry:

Biotechnology

Sector:

Healthcare

PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, and human african trypanosomiasis. It is also involved in developing PAX-102, an intranasal formulation of suramin for neurologic indications. The company was formerly known as Purinix Pharmaceuticals LLC and changed its name to PaxMedica, Inc. in April 2020. PaxMedica, Inc. was incorporated in 2018 and is based in Tarrytown, New York. PaxMedica, Inc. operates as a subsidiary of Tardimed Sciences LLC.

303 South Broadway
Tarrytown, NY 10591

CIK: 0001811623
ISIN: US70424C2035
CUSIP: 70424C104